Articles From: MarketAxess Announces Monthly Volume Statistics for December 2013 to NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism


2014/1/6
NEW YORK, Jan.
Sign-up for MarketAxess Announces Monthly Volume Statistics for December 2013 investment picks
Holzer & Holzer reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Ixia, Tile Shop Holdings, Inc. and FAB Universal Corporation.
Sign-up for Investor Alert: Upcoming Deadlines in Shareholder Litigation Involving Ixia, Tile Shop Holdings and FAB Universal investment picks
2014/1/6
Builds on successful deployment of current ST ARM-based SoCs, including its 'Cannes,' 'Monaco,' and 'Alicante' product families Leverages latest 64-bit ARM cores to support the increasing performance and memory requirements of future SoCs GENEVA, Jan.
Sign-up for Groundbreaking Architecture from STMicroelectronics Leads Industry Transition to 64-bit Computing for the Digital Home investment picks
FARGO, N.D. , Jan.
Sign-up for John Deere Electronic Solutions completes identity transition investment picks
2014/1/6
SEATTLE, Jan.
Sign-up for NanoString Technologies to Present at the JP Morgan 32nd Annual Healthcare Conference investment picks
PHILADELPHIA , Jan.
Sign-up for Aberdeen Greater China Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
BUFFALO, N.Y. , Jan.
Sign-up for CTG Announces Extension of 10b5-1 Plan to Facilitate Share Repurchases investment picks
2014/1/9
American Express Company (NYSE:AXP) plans to host its semi-annual Financial Community Meeting on Wednesday, February 5, 2014 at 2:30 p.m. (ET). At the meeting, Kenneth I.
Sign-up for American Express Plans Live Audio Webcast of Semi-Annual Financial Community Meeting investment picks
By John Kell DuPont Co.
Sign-up for DuPont Insider to Lead Performance Chemicals Unit After Spinoff investment picks
2014/1/13
Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has started a rolling submission to the U.S. Food and Drug Administration (FDA) of a Biologics License Application for MK-3475, the company’s investigational anti-PD-1 immunotherapy, for patients with advanced melanoma who have been previously treated with ipilimumab.
Sign-up for Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma investment picks
2014/1/23
PACIFIC COAST OIL TRUST (NYSE:ROYT) (the “Trust”), a perpetual royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today a cash distribution to the holders of its units of beneficial interest of $0.13396 per unit, payable on February 14, 2014, to unitholders of record on February 5, 2014.
Sign-up for Pacific Coast Oil Trust Announces February Cash Distribution investment picks
Chevron Corporation (NYSE:CVX) today reported in its interim update that earnings for the fourth quarter 2013 are expected to be comparable with third quarter 2013 results.
Sign-up for Chevron Issues Interim Update for Fourth Quarter 2013 investment picks
2014/1/15
HFF, Inc. (NYSE: HF or the Company) announced today that its Board of Directors has declared a special cash dividend of $1.83 per Common Share, payable February 6, 2014 to shareholders of record on January 27, 2014.
Sign-up for HFF, Inc. Declares Special Cash Dividend for Shareholders of Record as of January 27, 2014 and Also Announces 2014 Omnibus Awards to Reward Extraordinary Performance investment picks
2014/1/15
By Emily Glazer Altegrity, a defense contractor that has been hurt by government budget cuts, has enlisted restructuring advisers to help it cope with an unwieldy debt burden of roughly $1.8 billion, according to people familiar with the matter.
Sign-up for Defense Contractor Altegrity Enlists Restructuring Advisers -- Update investment picks
International stocks trading in New York closed higher Wednesday, with the Bank of New York index of American depositary receipts adding 0.3% to 151.27. The European index rose 0.4% to 150.62, the Asian index was essentially flat at 146.70, the Latin American index rose 0.2% to 272.77 and the emerging markets index increased 0.1% to 269.56. Among the companies with shares that actively traded were Teva Pharmaceutical Industries Ltd.
Sign-up for ADR Shares End Higher; Teva, Petrobras Shares Active investment picks
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will increase the price of all high VA (vinyl acetate) grades of Ateva® EVA by $0.04/pound, effective February 1, 2014 or as contracts allow.
Sign-up for Celanese Announces Ethylene Vinyl Acetate (EVA) Price Increase investment picks
Firm Capital Mortgage Investment Corporation - Confirmation of special year-end dividend amount and reminder to shareholders of the DRIP and share purchase plan programs Canada NewsWire TSX Symbol FC TORONTO , Jan.
Sign-up for Firm Capital Mortgage Investment Corporation - Confirmation of special year-end dividend amount and reminder to shareholders of the DRIP and share purchase plan programs investment picks
2014/1/9
OVERLAND PARK, Kan., Jan.
Sign-up for YRC Worldwide Reviewing Options After Unsuccessful MOU Vote investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0921191001&sourceType=1 http://www.ccnmatthews.com/logos/20070906-ptm1.jpg VANCOUVER, BRITISH COLUMBIA and JOHANNESBURG, SOUTH AFRICA --
Sign-up for Platinum Group Metals Adopts Advance Notice Policy investment picks
2014/1/13
By Therese Poletti, MarketWatch SAN FRANCISCO (MarketWatch) -- Remember last year how investors considering investing in Faceook Inc.'s IPO were stunned at its deal to buy the photo-sharing app company Instagram for $1 billion?
Sign-up for In Silicon Valley, $3 billion now price for start-ups investment picks
2014/1/9
Q3 Net Income $95,000 or $0.03 per share ($0.03 fully diluted) VANCOUVER, British Columbia, Jan.
Sign-up for Leading Brands, Inc. Announces Q3 and YTD Results investment picks
2014/1/9
EL PASO, Texas, Jan.
Sign-up for Western Refining, Inc. Announces Fourth Quarter and Full Year 2013 Earnings Conference Call investment picks
2014/1/13
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the launch of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay, an FDA approved breast cancer prognostic gene signature assay developed by NanoString Technologies, Inc. Prosigna provides a risk category and a numerical score to assess the probability of breast cancer recurrence in certain female breast cancer patients.
Sign-up for LabCorp to Offer New FDA approved Breast Cancer Prognostic Test investment picks
2014/1/7
-- Discover #HowScanagenicAreYou with iPad-compatible consumer 3D scanner --
Sign-up for Photo Release -- 3D Systems Unveils New iSense Consumer Scanner at CES investment picks
By Therese Poletti, MarketWatch SAN FRANCISCO (MarketWatch) -- Microsoft Corp.
Sign-up for Why Mulally staying put is bad for Microsoft investment picks
Plains All American Pipeline, L.P. (NYSE: PAA ) and Plains GP Holdings, L.P. (NYSE: PAGP) announced they plan to release quarterly earnings and hold their earnings webcasts and conference calls during 2014 according to the following schedule: The dates and times reflected above are subject to change due to unexpected developments.
Sign-up for Plains All American Pipeline, L.P. and Plains GP Holdings, L.P. Announce Quarterly Earnings Timing for 2014 investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review the company’s Biologics License Application (BLA) for Natpara ® (recombinant human parathyroid hormone 1-84, (rhPTH[1-84])) for the treatment of hypoparathyroidism.
Sign-up for NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MarketAxess Announces Monthly Volume Statistics for December 2013 to NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity